Biomemory
PrivateLast Round
Grant
Mar 4, 2026
Total Funding Raised
$23.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biomemory is a biotechnology company that develops IT-friendly DNA-based data storage and cybersecurity solutions for data center environments.
Sector
AI, Data & Cloud Infrastructure
Verticals
Cloud Infrastructure, Biotechnology, Computing Hardware, Data Protection
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biomemory Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Biomemory Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 4, 2026 | ||||
| Series A | Dec 10, 2024 | ||||
| Seed | Nov 28, 2022 |
Key People
Founding team and executive leadership
Biomemory Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blast.club | Series A |
| Prunay Impact Studio | Seed |
| Bpifrance | Series A |
| Paris Business Angels | Seed, Series A |
| ADNEXUS | Series A |
| Crédit Mutuel Innovation | Series A |
| Groupe Prunay | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
New entity established for R&D, production, and customer support.
- Mar 4, 2026
Received grant funding to support operations.
Biomemory Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biomemory's valuation, stock price, and market status.